Related Experiment Video
Updated: Aug 9, 2025

High-Resolution Three-Dimensional Imaging of the Footpad Vasculature in a Murine Hindlimb Gangrene Model
Published on: March 16, 2022
Symptomatic Popliteal Artery Aneurysms in Recently SARS-CoV-2-Infected Patients: The Microangiopathic Thrombosis That
Laura Capoccia1, Wassim Mansour2, Luca di Marzo2
1Department of Surgery, Vascular Surgery Division, SS Filippo e Nicola Hospital, 67051 Avezzano, Italy.
Background:
Arterial and venous thrombosis are complications in SARS-CoV-2-infected patients. The microangiopathic thrombosis in affected patients can compromise results in urgent limb revascularizations. Aim of our study is to report on the incidence of symptoms development in patients affected by popliteal artery aneurysm (PAA) and to analyze the effect of COVID-19 infection on outcomes.
Methods:
Data on patients surgically treated for PAA from the massive widespread of COVID-19 vaccine (March 2021) to March 2022 were prospectively collected. Factors considered for analysis were: presence of symptoms, aneurysm diameter and length, time from symptom onset and hospital referral, ongoing or recently COVID-19 infection. Outcomes measures were: death, amputation, and neurological deficit.
Results:
Between March 2021 and March 2022, 35 patients were surgically treated for PAA. Among them 15 referred to our hospital for symptomatic PAA and were urgently treated. Urgent treatments included both endovascular procedures and open surgeries. Nine out of 15 symptomatic patients had an ongoing or recently recovered COVID-19 infection. COVID-19 infection was strongly associated to symptoms development in patients affected by PAA and to surgical failure in those patients (OR 40, 95% CI 2.01-794.31, p = 0.005).
Conclusion:
In our series, presence of COVID-19 infection was strongly associated to ischemic symptoms onset and to complications after urgent treatment in symptomatic patients.
Insights
COVID-19 infection significantly increases the risk of symptomatic popliteal artery aneurysms (PAA) and complications following urgent revascularization surgery. This highlights the importance of considering recent or ongoing SARS-CoV-2 infection in PAA patients.
Area of Science:
- Vascular Surgery
- Infectious Diseases
- Thrombosis
Background:
- SARS-CoV-2 infection is linked to arterial and venous thrombosis.
- Microangiopathic thrombosis can negatively impact urgent limb revascularization outcomes.
- Popliteal artery aneurysms (PAA) are susceptible to thrombotic complications.
Purpose of the Study:
- To determine the incidence of symptom development in patients with PAA.
- To analyze the impact of COVID-19 infection on PAA patient outcomes.
- To investigate the association between COVID-19 and PAA-related symptoms and surgical results.
Main Methods:
- Prospective data collection from PAA patients surgically treated between March 2021 and March 2022.
- Analysis of factors including symptom presence, aneurysm characteristics, referral time, and COVID-19 status.
- Evaluation of outcomes such as death, amputation, and neurological deficit.
Main Results:
- Fifteen of 35 surgically treated PAA patients presented with symptoms requiring urgent intervention.
- Nine of these 15 symptomatic patients had recent or ongoing COVID-19 infection.
- COVID-19 infection showed a strong association with symptom development (OR 40) and surgical failure in PAA patients.
Conclusions:
- COVID-19 infection is significantly associated with the onset of ischemic symptoms in PAA patients.
- COVID-19 is linked to increased complications after urgent surgical treatment for symptomatic PAA.
- Consideration of SARS-CoV-2 status is crucial for managing PAA patients.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease I: Introduction
Aneurysm III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis

